Barrington Research Maintains Outperform on US Physical Therapy, Raises Price Target to $122
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Michael Petusky has maintained an Outperform rating on US Physical Therapy (USPH) and increased the price target from $120 to $122.
March 01, 2024 | 3:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barrington Research maintains an Outperform rating on US Physical Therapy and raises the price target from $120 to $122.
The maintenance of an Outperform rating combined with an increased price target suggests a positive outlook on US Physical Therapy's stock by Barrington Research. This could lead to increased investor confidence and potentially a short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100